
Business
Aeglea BioTherapeutics Inc. (NASDAQ: AGLE) Have Jumped 9.74% YTD, What Will Happen Next
During the last session, Aeglea BioTherapeutics Inc. (NASDAQ:AGLE)’s traded shares were 0.41 million, with the beta value of the company hitting 1.62. At the end